Terry Smith's CPRX Position Overview
Terry Smith (via Fundsmith Llp) currently holds 844,887 shares of Catalyst Pharmaceuticals, Inc. (CPRX) worth $20.92 M, representing 0.16% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Terry Smith has maintained this position in CPRX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 654,721 shares. Largest reduction occurred in Q1 2026, reducing 2.52 M shares.
Analysis based on 13F filings available since 2013 Q2
Terry Smith's Catalyst Pharmaceuticals (CPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Catalyst Pharmaceuticals (CPRX) Trades by Terry Smith
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -2.52 M | Reduce 74.88% | 844,887 | $24.76 |
| Q3 2025 | +654,721 | Add 24.17% | 3.36 M | $19.70 |
| Q2 2025 | +557,812 | Add 25.93% | 2.71 M | $21.70 |
| Q1 2025 | +2.15 M | New Buy | 2.15 M | $24.25 |
Terry Smith's Catalyst Pharmaceuticals Investment FAQs
Terry Smith first purchased Catalyst Pharmaceuticals, Inc. (CPRX) in Q1 2025, acquiring 2,151,274 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Terry Smith has held Catalyst Pharmaceuticals, Inc. (CPRX) for 5 quarters since Q1 2025.
Terry Smith's largest addition to Catalyst Pharmaceuticals, Inc. (CPRX) was in Q1 2025, adding 2,151,274 shares worth $52.17 M.
According to the latest 13F filing for Q1 2026, Terry Smith's firm, Fundsmith Llp, owns 844,887 shares of Catalyst Pharmaceuticals, Inc. (CPRX), valued at approximately $20.92 M.
As of the Q1 2026 filing, Catalyst Pharmaceuticals, Inc. (CPRX) represents approximately 0.16% of Terry Smith's publicly disclosed stock portfolio, making it one of their key holdings.
Terry Smith's peak holding in Catalyst Pharmaceuticals, Inc. (CPRX) was 3,363,807 shares, as reported at the end of Q3 2025.